Answers are grounded in this paper and cite their sources.
Background: Serum leucine-rich alpha-2 glycoprotein (LRG) has been proposed as a biomarker of inflammatory activity in ulcerative colitis (UC). This study investigated the associations of serum LRG with endoscopic and histological disease activity and their longitudinal changes. Methods: Thirty-six patients with UC who underwent two colonoscopies with biopsies were retrospectively evaluated. Correlations between serum LRG and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), Geboes scoring system (GS), and GS subgrades were assessed at the most inflamed site and across six colonic segments. Associations between longitudinal changes (Δ) were also evaluated. Results: Serum LRG showed moderate correlations with UCEIS at the most inflamed site (r = 0.480) and across the entire colon (r = 0.510). LRG showed a weak but significant correlation with GS at the most inflamed site (r = 0.355), whereas its correlation with total GS was weak and non-significant (r = 0.324). Across six colonic segments, LRG showed moderate correlations with GS Grades 0, 1, 2B, and 3. ΔLRG showed moderate correlations with Δtotal UCEIS (r = 0.575), Δtotal GS (r = 0.458), and changes in Grades 0, 1, 2B, and 3 across the entire colon (r = 0.488–0.578). Conclusions: Longitudinal changes in serum LRG were associated with changes in endoscopic and histological disease activity, particularly with whole-colon histological inflammation involving neutrophil-related GS subgrades. Further validation in larger cohorts is warranted.
No takes yet. Share an insight, caveat, or question.
Tsuchiya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: